Risk Factors for Child Maltreatment Fatalities in a National Pediatric Inpatient Database

Juliana M Kennedy1, Stephen Lazoritz2, Vincent J Palusci3

  • 1Department of Pediatrics, Grossman School of Medicine, New York University, New York, New York; and juliana.kennedy@nyulangone.org.

Hospital Pediatrics
|February 15, 2020
PubMed

Insights

Child maltreatment fatalities are linked to specific injury types and clinician identification of physical abuse, not just demographics. Early recognition of these factors is crucial for preventing child deaths.

Area of Science:

  • Pediatric Health
  • Public Health
  • Forensic Medicine

Background:

  • Child maltreatment (CM) is a significant public health issue with fatal outcomes.
  • Identifying risk factors for CM fatalities is crucial for clinical intervention and prevention.

Purpose of the Study:

  • To identify demographic and clinical risk factors associated with child maltreatment fatalities in hospitalized children.
  • To aid clinicians in recognizing at-risk children to reduce mortality.

Main Methods:

  • Analysis of the 2012 Kids' Inpatient Database for children <5 years with CM diagnosis codes.
  • Bivariate and multivariate analyses to compare risk factors with in-hospital fatality.
  • Logistic regression to differentiate outcomes for specific maltreatment codes.

Main Results:

  • 10,825 children <5 years had inpatient CM diagnoses.
  • Clinical variables (drowning, ingestions, burns) and specific physical abuse diagnoses were significant risk factors for fatality.
  • Children with physical abuse diagnoses had ~3 times higher odds of dying.

Conclusions:

  • Infancy and lower income are risk factors, but injury type and clinician-identified physical abuse are more critical predictors of fatality.
  • Focusing on injury specifics and recognizing signs of physical abuse can improve outcomes for children at risk.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
184
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
204
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
159
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
190
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
146
Anorexia Nervosa01:28

Anorexia Nervosa

Anorexia nervosa is a complex and severe eating disorder characterized by an intense fear of weight gain, an unrelenting pursuit of thinness, and a distorted body image. It often leads to dangerously low body weight relative to an individual's age and height. This disorder is marked by significant physical and psychological consequences, making it one of the most life-threatening psychiatric illnesses.
Symptoms and Physical Effects
Individuals with anorexia nervosa commonly exhibit extreme...
787